Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway.
about
Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXAControl of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling.MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner.
P2860
Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Oncogenic KRAS sensitizes prem ...... vation of the MEK/ERK pathway.
@en
type
label
Oncogenic KRAS sensitizes prem ...... vation of the MEK/ERK pathway.
@en
prefLabel
Oncogenic KRAS sensitizes prem ...... vation of the MEK/ERK pathway.
@en
P2093
P2860
P50
P356
P1433
P1476
Oncogenic KRAS sensitizes prem ...... vation of the MEK/ERK pathway.
@en
P2093
Annalisa Conti
Carlotta Cancelliere
Daniele Lecis
Domenico Delia
Henning Walczak
Maria Teresa Majorini
Pierfausto Seneci
Richard Elliott
P2860
P304
10994-11008
P356
10.18632/ONCOTARGET.3552
P407
P577
2015-05-01T00:00:00Z